A B S T R A C T Since estrone sulfate (E1S) is present at high concentration in plasma, we have examined the parameters of the plasma estrone, estradiol, E1S system. The metabolic clearance rate of EiS was 157 liter/day (range 70-292) in men and women. Estimated plasma production rates of E1S were (/Agrams per day): men, 77; women, early follicular phase, 95; women, early luteal phase, 182. The conversion of plasma estrone and estradiol to EiS was measured and from these data and the metabolic clearance rates of the estrogens, the transfer factors were p51'18 = 0.54 and p'2'1' = 0.65. Using average production rates, all plasma E1S could be shown to be derived from plasma estrone and estradiol.
INTRODUCTION
Estrone-3-sulfate (E1S)1 is the major component of the conjugated equine estrogens and of other estrogenic preparations and has been used for over 30 years for treatment of the postmenopausal woman. Although estrone sulfate has been identified in human urine, little is known of its blood levels and metabolism. Twombly and Levitz showed that estrone sulfate had a long halfReceived for publication 24 September 1971 and in revised form 22 November 1971. 1 Abbreviations used in this paper: DCC, dicyclohexylcarbodiimide; DHS, dehydroeipandrosterone sulfate; DMF, dimethyl formamide; E1, estone; E2, estradiol; E1S, estrone-3-sulfate; MCR, metabolic clearance rate; RBC, red blood cells; TLC, thin-layer chromatography.
life in blood (1) , and Purdy, Engel, and Oncley (2) found that it was the major plasma metabolite of estradiol and that it was present in high concentration in pregnancy. During previous studies of estrogen metabolism we had postulated (3) that there was another plasma estrogen compartment in equilibrium with plasma estrone (E1) and estradiol (E2). Since it seemed probable that this compartment was estrone sulfate, we initiated studies of the origin, rates of metabolism, blood levels, and conversions of estrone sulfate. These studies have confirmed the finding that E1S is an important plasma metabolite of estradiol and have defined the production rate of E1S and its interconversions with estrone and estradiol.
METHODS
Materials. Estrone-6,-7-'H, estradiol-17fi-6,7-8H, estrone-3-NH4-sulfate-6,-7-8S (40 Ci/mmole), and estrone-4-1'C and estradiol-17fi-4-"'C (45 mCi/mmole) were purchased from New England Nuclear Corp., Boston, Mass. Portions of 8H-and '4C-labeled steroids were combined and radiochemical purity demonstrated before use by constancy of 8H : "C ratio through a series of derivatives as shown in Fig. 1 .
Estrone-3-NH4-sulfate-4-14C (45 mCi/mmole) was prepared from estrone-4-"C ( (3, 5, 6) . Column chromatography was performed on small Sephadex LH-20 columns (Pharmacia Fine Chemicals Inc., Piscataway, N. J.) which separate El and E2 as described previously (5) .
Subjects. Normal subjects, (Nos. 2-18), ages 18-30 yr were hospitalized at the National Institutes of Health and received no medications. Each woman had normal cyclic menses. Subject 16 was a 28 year old euthyroid subject with a benign thyroid nodule. Subject 1 was a normal man, age 48, in good health.
Clearance rates. Determinations of metabolic clearance rate (MCR) were started at 7:30 a.m. with subjects reof tritium in plasma estrone, estradiol, maining in the basal state until the end of the study. The infusion techniques were performed as described previously (7) .
All short infusions were begun with a 10 ,uCi bolus given i.v. over 1 min, 30 min later an infusion of approximately 10 ,uCi/hr was begun and maintained at a constant rate until the end of the study. The duration of the short infusions was usually 165 min from the time of the bolus and varied from 135 min in earlier studies to 210 min in later studies, 3040 ml of blood was drawn at various times after the bolus was given; the heparinized plasma was separated by centrifugation and stored at -16°C until extracted.
To measure the MCR of E1S, 20-40 ,uci of ES-3H was injected over 1 min at 9:00 a.m. via an antecubital vein. 10-ml blood samples were taken at i, 1, 2, 4, 6, and 8 hr and 20-35-ml blood samples were taken at 11, 14, 19 , and 24 hr. Blood was heparinized, centrifuged immediately, and the plasma frozen at -15°C until extracted. Subjects were kept at bed rest with bathroom privileges and fed light meals as desired for the duration of the study except for subjects 1 and 2, who were allowed normal daily activities.
Calculationts. The symbols and calculations for the several parameters of the system are essentially those used by Horton and Tait (8 (3, 6) . After the first fou evident that in no case d cantly after the first deri all cases the 'H :14C ra the same as that of the described (5) and normal values for our laboratory are shown in Table III . These values include all patients used 207 liters/day in the infusion studies and agree well with those obtained .
by others (9) (10) (11) Counting methods. Radioactivity was measured as previously described (3, 6) . All samples were counted to either a minimum of 3000 counts in the carbon channel or for 100 min. Samples were spot checked for differences in quenching and none were found.
Plasma estrogen concentrations. Methods for measurement of plasma concentration of E,, E2, and ES have been RESULTS ES metabolic clearance rates. The data for the disappearance of E1S-3H from plasma are shown in Table  I . When the data for each subject were analyzed, it was found that in all cases, disappearance curves could be fitted by a single straight line, consistent with a one-compartment system described by a single Y intercept (volume of distribution) and a single slope (fractional pool turnover rate). Two representative studies are shown in Fig. 2 . The lines of best fit were calculated by computer program, and the points shown are the data points. Metabolic clearance rates were calculated, assuming a one-compartment model, by the formula MCR= VY, where V = the volume of distribution and ' = fractional pool turnover rate per unit The validity of calculation of MCRiS based on the assumption of a one-compartment system was tested by comparing in the same subject the MCR obtained in this way with that obtained by the constant infusion technique. In this study, we injected a bolus of E1S into a normal subject. No. 6, and established a MCREsS from the plasma disappearance curve over 8 hr. Subsequently, a calculated bolus of E1S-'H was given followed by a continuous infusion of ES-3H for a further 8 hr achieving a constant plasma level of E1S-'H (Fig. 3) . From the data obtained after the injection of E1S-'H (Table   I ), a MCR of 207 liter/day was calculated. The MCR calculated from the constant infusion data (Table III) was 194 liter/day. These two MCR are not different.
The production rate of E1S was calculated from the MCREs and the measured plasma concentrations of E1S (Table II) . Average values for MCR and plasma EiS concentrations in both men and women were used. In men, ES production averaged 77 Ag/day, not greatly different from E1 and E2 production rates. In women, ES production averaged 95 Ag/day during the early follicular phase; and 182 ,Ag/day during the luteal phase. Follicular and luteal phase ES production rates are compared with follicular and luteal E, and E2 production rates (Table II) . To convert EiS production rates to equivalent E1 production rates, multiply EiS values by 0.71.
Conversion ratios. CEiSEl and CE1S2 were measured in five subjects (Table III) . Shown in Table III are the plasma levels of tritium in E1,E2, and ElS; conversion ratios have been calculated at each time point.
Though plasma levels of E1S-3H, Ei-'H, and E2-'H are increasing, the conversion ratios are constant and appear to represent equilibrium values. Each series of conversion ratios was examined for systematic trends or deviations from the mean. Only in subject 11 was there a suggestion that CE1S`l was increasing during the period of observation. In subject 6, plasma levels of El-3H and E1S-'H reached equilibrium as did the conversion ratios and the conversion ratio of 0.025, was the same as the average of the other subjects. The conversion ratio (CEi1"i) averaged 0.017 in five studies.
Transfer factors (p) were calculated using these conversion ratios and values for MCREs and MCREnss either measured in the same subject (Table IV) or using average values from our laboratory (Table III) (Table III) .
The conversion ratio (C'1"s2) averaged 0.0023 in four studies, about 1/10 that for the conversion of E1S to estrone. Transfer factors were then calculated using these conversion ratios and values for MCRE, and MCREs either measured in the same subject (Table V) or using average values from our laboratory (Table  II) (Table III) .
and used for calculations in subject 8). The transfer factor (pElEis) averaged 0.54 (Table IV) .
Conversion of Es to ES. The data obtained from
estradiol-6,7-3H infusions are shown in Table V (13, 14) . E1S has been the major urinary estrogenic metabolite. As Purdy et al. (2) showed, it is also the major plasma metabolite of estradiol. We had postulated that there was a large plasma compartment that slowly exchanged with plasma estrone and estra- (19) . However, the fractional pool turnover rate of E1S of 3.3 pools/day is about the same as the fractional pool turnover rates of other steroid sulfates (15, (17) (18) (19) . Thus, the higher MCREXS must be associated with a larger volume of distribution of E1S, and in fact its volume of distribution of about 50 liters is higher than those of the other steroids (15, 17, 18) which have lower MCR. Only pregnenolone sulfate had a higher MCR than E1S but it had a relatively small volume of distribution (7 liters) and a higher fractional turnover rate almost equal to that of some unconjugated steroids (18) .
The volume of distribution of the steroid sulfate depends on the binding of the sulfates to plasma proteins, in particular to albumin. Binding to albumin in man has been demonstrated by Puche and Nes (20), Sandberg and Slaunwhite (21), and Plager (22) . Puche and Nes, Plager, and Wang and Bulbrook (23) noted that all steroid sulfates tested competed for the same binding sites. However, the association constants were influenced by the nature of the steroid. The association constant of DHS with albumin has been reported as 0.6-2 X 10' liter/mole (20, 22) , whereas the E1S binding constant was estimated at 2 X 104 liter/ mole (24) . Although these binding affinities were not obtained in the same system, the association of lower affinity constants with higher volumes of distribution is apparent. It therefore seems probable that the clearance rates of the steroid sulfates vary inversely with the tightness of binding to albumin which in turn determines the volume of distribution.
Using the average MCRE1s and mean ELS plasma concentrations, we found that plasma production rates of E1S were similar to those of estrone and estradiol in men and women. Although we have not looked for possible variations of E1S concentrations throughout the day, it can be shown that they will not vary greatly because of the low fractional pool turnover rate (ay). Thus, the E1S production rates need not he corrected for a mean plasma EiS concentration, and should closely approximate the 24-hr production rates of E1S.
Since sulfokinases are present in peripheral tissues as well as in the gonads and adrenal cortex, we could not know to what extent E1S was either secreted' or produced from peripheral transformation of plasma precursors. We therefore calculated the contributions of plasma estrone and estradiol to the E1S production rate. To do this, we used our values for transfer factors, pE1E1S, pE8; pE1SE1 p1SE2 (Tables II-V) as well as the average transfer factors, pEB2A, pE2A1 (25, 26) .
The following three equations give solutions for the net amount of steroid entering the plasma from all sources (shown by [ ] ) other than from conversion of the two other steroids:
Since the production rates (PR) and transfer factors are known, the equations can be solved for the [ ] values. These values are not true secretion rates since they would include any steroid produced from other precursors. For example, [EL] would include that estrone derived from plasma androstenedione and testosterone as well as that moiety that is secreted.
The derived data are given in Table VI . For each subgroup, [E1S] was negative. This means that the production rate calculated to result from conversion of plasma estrone and estradiol is higher than that calculated by direct measurement of the MCRisu and plasma E1S concentration. Hence, there is no need to postulate glandular secretion of E1S. The lack of correspondence of the data must be explained and serves to point out the many sources of discrepancies in all studies such as this.
The first and most important reason for lack of correspondence in calculations such as these is not really "error" but relates to the large range of normal average values for metabolic clearance rates and transfer factors that are used. Inspection of published data for metabolic clearance rates of E1 and E2 (3, 25, 26) reveals not only a large range of values for normals but also for groups of normals studied in the same laboratory (25, 26) . This same large range of normal values is also evident from our data for pE1ElsI p 2 1 , and MCREls. Since our study included only a small sample from a population with a large normal range, it is possible that our average values for pE1E1S, p 2B1S could be considerably higher than the true mean for the normal population. Agreement between the calculations would be possible only if all parameters were measured in the same normal subjects. Secondly, average values for estradiol concentrations in men reported by us previously (5) and used for our calculations of E2 production rates are somewhat higher than more recent values of 20-25 pg/ml reported by other laboratories (9) (10) (11) . The errors in measurement of low estrogen concentrations by radioligand assays tend to cause high values which would result in overestimation of production rates. The consistent finding that estrogen production rates, calculated from dilution of labeled estrogen into urinary metabolites, are smaller than those calculated from the MCR and plasma concentration is further evidence that the latter method overestimates the production rate. Next, the known diurnal variations in plasma estrone concentration (27, 28) and possibly of estradiol, mean that production rates obtained using morning plasma estrogen concentrations will systematically overestimate the 24 hr estrogen production rate of these unconjugated estrogens. Finally, since plasma estradiol and estrone have plasma turnovers of about 50 pools/day and E1S turnover rate is 3.3 pools/day, plasma concentrations of E1S will lag behind plasma estrone and estradiol by 6-12 hr. Therefore, it will be difficult to arrive at correct sampling times to estimate the contributions of estrone and estradiol to E1S production rates.
Since most of the errors discussed will cause overestimation of estrone and estradiol blood production rates, the amount of EiS calculated to arise from these sources will also be overestimated. Nevertheless, all E1S found in plasma can be accounted for merely by using mean values ± standard deviations for production rates and p used in the calculations. Hence, it is untenable The transfer factor, pE 11 of 0.21 was derived from the conversion ratios obtained from the short infusions of ES during which plasma levels of E1S-3H, E1-3H, and E2-3H were increasing in four of the five studies.
However, pE1SEi and pE1SE2 appeared to be at equilibrium.
The pE1SE1 of 0.21 agrees closely to that of 0.15 reported recently by Longcope (16) . The transfer factor, pESE2 was only 10% of that for estrone (Table IV) .
Since pE1E2 is also about 10% (25, 26) Although pE1SE1 and pE1SE2 were apparently at equilibrium, computer simulations of these studies' using the SAAM program of Berman and Weiss (12) have shown that these conversion ratios cannot be at equilibrium and that the true conversion ratio may be greater by about 15%. Short sampling times and variability in the determinations mask this trend. For the purposes of understanding these facets of estrone sulfate metabolism, the values used in our calculations are sufficiently accurate although they are not equilibrium values.
In contrast to the low biologic potency of orally administered estrone and estradiol, EiS is an active oral estrogen. Our data confirm that it is rapidly absorbed from the gut and reaches the peripheral circulation without significant metabolism by the liver. Since 0.5 mg of estrone sulfate is an adequate replacement dose for many postmenapausal women, we have calculated that the plasma estrone production rate resulting from this dose is 70 /Lg/day (0.5 X 0.7 x 0.2).' Similarly, the resultant estradiol production rate would be 7 gg/ day. The minimal estrogen production rates that cause either vaginal cornification or endometrial hyperplasia are unknown but Grodin and McDonald 5 found that an estrone production rate greater than 40 ,g/day (by urinary isotope dilution) induced endometrial hyperplasia in women. The estrone production rate of normal postmenapausal women calculated from plasma concentrations and metabolic clearance rates is about 40 Ag/day (30) (12) . We were able to show that the dose of E1 -3H or E2-3H given as a bolus to begin the short infusions adequately set the plasma level of E -3H or E2-3H at near equilibrium levels; and that in addition, a constant amount of E1S -3H is entering the plasma EIS pool from the time of the bolus at time 0.
Thus, the instantaneous change in E1S-3H is described by the following, dEiSt = k1Eit, -yE1St., where E1St. is the instantaneous level of E1S-3H at time t,; El is the instantaneous level of E1 -3H at time t,; k1 is the fractional turnover of El -3H to E1S-3H; and y is the total rate of removal of ElS-3H as given in Table I The same formula holds for CE2EIS substituting appropriate values for E2 and -y. All conversion ratios shown in Tables IV and V were calculated using this formula and, where possible, the actual measured value for oy. Otherwise, average values for oy were used from Table I . Since each infusion had at least three plasma samples at different time points, conversion ratios were calculated at each time point during a single infusion and averaged, yielding the values shown in Tables IV and V. Validity of these calculations was confirmed by using data from subjects 7 and 8 in whom we had estimates of all MCR and plasma concentrations for computer simulation using the SAAM program of Berman and Weiss (12) . There was close agreement between conversion ratios predicted by the computer program and the conversion ratios calculated by the above formula.
